News
Meet us at the following events
- Bio Europe Spring 2012
Amsterdam, Netherlands
19-21 March 2012 - ADA Annual Meeting 2012
Philadelphia, USA
June 8-12 2012
- BIO 2012
Boston, USA
18-21th June 2012
Metabrain Research is a Partnering Research Organization (PRO)
- Focused on early stage drug discovery
- Specialized in metabolic disorders such as diabetes and obesity
- Driving innovation through collaborative research programs
- Exploring connections between neurodegenerative and metabolic diseases
We operate as an integrated drug discovery platform in partnership with pharmaceutical industries, biotech as well as academic institutions with applications in the food and OTC businesses.
About usKnow-how
Our expertise in energy metabolism can be applied to both metabolic disorders and neurodegenerative diseases
Know HowDiscovery Platform
Our preclinical drug discovery platform integrates medicinal chemistry and expert biology competencies, conceived for optimal hit generation and lead optimization processes.
Discovery PlatformPartnership Offers
Our flexible approach to drug discovery collaborations & alliances aims to align with our pharma & biotech partners' strategies & imperatives.
Partnering offers